Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Improving Sarcopenia During Chemotherapy

Authors not listed

National Taiwan University Hospital · 2025

Abstract

This study aims to investigate whether a high-protein nutritional supplement (ETHANWELL BALANCED) can help improve muscle strength and reduce fatigue in cancer patients who are at risk of sarcopenia (age- or disease-related muscle loss) during chemotherapy. Sarcopenia is common in older adults and cancer patients and can lead to weakness, poor treatment tolerance, and reduced quality of life. Participants aged 40 and older, receiving chemotherapy, and showing early signs of sarcopenia will be randomly assigned to two groups. The experimental group will receive nutritional education and take a high-protein nutritional drink three times per day for 8 weeks. Both groups will continue their usual medical care and perform simple resistance exercises at home. Researchers will measure changes in grip strength, fatigue, quality of life, and nutritional status over a 12-week period. This study will help determine whether early nutrition intervention can improve treatment outcomes and quality of life for cancer patients with sarcopenia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-10 MST

Cite this

APA
Anonymous. (2025). Improving Sarcopenia During Chemotherapy. <em>National Taiwan University Hospital</em>. https://clinicaltrials.gov/study/NCT07114588
Vancouver
Anonymous. Improving Sarcopenia During Chemotherapy. National Taiwan University Hospital. 2025.
BibTeX
@misc{anon2025Improv, title = {Improving Sarcopenia During Chemotherapy}, author = {Anonymous}, journal = {National Taiwan University Hospital}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings